Logo


Troubles behind it, Cadila surges aheadlkjlkjkjlkjj

Cadila hopes to double its revenue from the US in three years

Cadila Healthcare
Cadila Healthcare

ThesharesofpharmamajorCadilaHealthcare,alsoknownasZydusCadila,havebeenonarollforthepastfewweeks.Thestock'svaluerosealmost55percenttoasix-monthhighofRs548.35onJune12.CadilahasedgedpastLupintobecomethesecond-mostvaluablepharmaceuticalcompanybymarketcapitalisationatRs54,719crore. Thereweretwotriggersbehindthissharprise;one,theUSFoodandDrugAdministration’sapprovalforthegenericversionofanulcerativecolitisdrugLialda(whichhassalesof$1.14billionintheUS);andtwo,theexpectationofFDA ...